Holen Sie sich die Stockscreener-App
0.181
2.65%
-0.004
Schlusskurs vom Vortag:
$0.185
Offen:
$0.187
24-Stunden-Volumen:
9,827
Relative Volume:
0.04
Marktkapitalisierung:
$1.37M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-5.65M
KGV:
-0.1446
EPS:
-1.2521
Netto-Cashflow:
$-5.88M
1W Leistung:
-0.83%
1M Leistung:
-18.51%
6M Leistung:
-70.63%
1J Leistung:
-85.82%
1-Tages-Spanne:
$0.1801
$0.187
1-Wochen-Bereich:
$0.1732
$0.1948
52-Wochen-Spanne:
$0.1732
$1.34
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Firmenname
Virax Biolabs Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare VRAX vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.184 | 1.37M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
452.38 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.66 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.83 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
If You Invested $1,000 in Virax Biolabs Group Ltd (VRAX) - Stock Titan
Virax Biolabs (NASDAQ: VRAX) COO discloses multiple long-dated stock options - Stock Titan
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM - The Globe and Mail
Virax Biolabs (VRAX) backs reverse split range and 2M-share incentive plan - Stock Titan
Virax Biolabs (VRAX) CEO reports holdings in shares and options - Stock Titan
Virax Biolabs Group Ltd (VRAX) director discloses multiple option grants - Stock Titan
Virax Biolabs (VRAX) CFO Jason Davis becomes reporting insider with Form 3 - Stock Titan
Virax Biolabs (VRAX) director files initial insider ownership report - Stock Titan
Momentum Shift: What are Virax Biolabs Group Limiteds earnings expectations2026 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
00019 Should I Buy - Intellectia AI
PRH Should I Buy - Intellectia AI
VRAX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 67.6% in February - Defense World
ONEG.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
US Market Recap: Will Virax Biolabs Group Limited benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Volume Summary: How much upside does HSDT haveWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TCGL Should I Buy - Intellectia AI
Day Trade: Is now the right time to enter AEISWeekly Trend Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SKX PE Ratio & Valuation, Is SKX Overvalued - Intellectia AI
VRAX PE Ratio & Valuation, Is VRAX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Nektar Therapeutics (NKTR) - The Globe and Mail
IVF Should I Buy - Intellectia AI
Exit Recap: Is Oriental Culture Holding LTD stock risky to hold nowEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan - The Globe and Mail
Bull Bear: Does Virax Biolabs Group Limited offer margin of safetyMarket Activity Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Group (NASDAQ:VRAX) Upgraded at Zacks Research - Defense World
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright By Investing.com - Investing.com South Africa
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright - Investing.com India
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
HC Wainwright Reaffirms “Buy” Rating for Virax Biolabs Group (NASDAQ:VRAX) - Defense World
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target - TipRanks
VRAX Analyst Forecasts - Quiver Quantitative
Why Virax Biolabs Group Limited stock is favored by top institutions - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - Chartmill
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
Finanzdaten der Virax Biolabs Group Ltd-Aktie (VRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):